{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:15:38Z","timestamp":1789416938679,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-09087-4","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:16:26Z","timestamp":1764591386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fibroblast TGF-\u03b2 signaling defines spatial tumor ecosystems linked to immune checkpoint blockade resistance"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6192-2116","authenticated-orcid":false,"given":"Seo-Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0180-189X","authenticated-orcid":false,"given":"Youngjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"9087_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"9087_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai, A. A., Solomon, B. J., Sequist, L. V., Gainor, J. F. & Heist, R. S. Lung cancer. Lancet 398, 535\u2013554 (2021).","journal-title":"Lancet"},{"key":"9087_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6621-1","volume":"20","author":"C Wang","year":"2020","unstructured":"Wang, C., Wu, Y., Shao, J., Liu, D. & Li, W. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer. BMC Cancer 20, 150 (2020).","journal-title":"BMC Cancer"},{"key":"9087_CR4","unstructured":"Society, A. C. Lung Cancer Survival Rates. (2024)."},{"key":"9087_CR5","doi-asserted-by":"publisher","first-page":"1127071","DOI":"10.3389\/fimmu.2023.1127071","volume":"14","author":"K Zhou","year":"2023","unstructured":"Zhou, K., Li, S., Zhao, Y. & Cheng, K. Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer. Front. Immunol. 14, 1127071 (2023).","journal-title":"Front. Immunol."},{"key":"9087_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48700-8","volume":"15","author":"M De Zuani","year":"2024","unstructured":"De Zuani, M. et al. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer. Nat. Commun. 15, 4388 (2024).","journal-title":"Nat. Commun."},{"key":"9087_CR7","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","volume":"184","author":"BA Luca","year":"2021","unstructured":"Luca, B. A. et al. Atlas of clinically distinct cell states and ecosystems across human solid tumors. Cell 184, 5482\u20135496 e5428 (2021).","journal-title":"Cell"},{"key":"9087_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00703-w","volume":"8","author":"S Zeng","year":"2024","unstructured":"Zeng, S. et al. Integrative analysis of pan-cancer single-cell data reveals a tumor ecosystem subtype predicting immunotherapy response. NPJ Precis. Oncol. 8, 205 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"9087_CR9","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massague","year":"2023","unstructured":"Massague, J. & Sheppard, D. TGF-beta signaling in health and disease. Cell 186, 4007\u20134037 (2023).","journal-title":"Cell"},{"key":"9087_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng, Z. et al. TGF-beta signaling in health, disease, and therapeutics. Signal Transduct. Target Ther. 9, 61 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"9087_CR11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41401-024-01235-6","volume":"45","author":"ZJ Chia","year":"2024","unstructured":"Chia, Z. J., Cao, Y. N., Little, P. J. & Kamato, D. Transforming growth factor-beta receptors: versatile mechanisms of ligand activation. Acta Pharm. Sin. 45, 1337\u20131348 (2024).","journal-title":"Acta Pharm. Sin."},{"key":"9087_CR12","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","volume":"54","author":"J Zhu","year":"2022","unstructured":"Zhu, J. et al. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. Exp. Mol. Med. 54, 2060\u20132076 (2022).","journal-title":"Exp. Mol. Med."},{"key":"9087_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"9087_CR14","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","volume":"40","author":"S Salcher","year":"2022","unstructured":"Salcher, S. et al. High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. Cancer Cell 40, 1503\u20131520 e1508 (2022).","journal-title":"Cancer Cell"},{"key":"9087_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54671-7","volume":"15","author":"Y Takano","year":"2024","unstructured":"Takano, Y. et al. Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development. Nat. Commun. 15, 10637 (2024).","journal-title":"Nat. Commun."},{"key":"9087_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.694071","volume":"9","author":"D Che","year":"2021","unstructured":"Che, D. et al. KRT6A promotes lung cancer cell growth and invasion through MYC-regulated pentose phosphate pathway. Front. Cell Dev. Biol. 9, 694071 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"9087_CR17","doi-asserted-by":"publisher","first-page":"1253238","DOI":"10.3389\/fonc.2023.1253238","volume":"13","author":"J Zhao","year":"2023","unstructured":"Zhao, J. & Xu, Y. PITX1 plays essential functions in cancer. Front. Oncol. 13, 1253238 (2023).","journal-title":"Front. Oncol."},{"key":"9087_CR18","first-page":"23114","volume":"12","author":"N Huang","year":"2020","unstructured":"Huang, N. et al. Intracellular and extracellular S100A9 trigger epithelial-mesenchymal transition and promote the invasive phenotype of pituitary adenoma through activation of AKT1. Aging (Albany NY) 12, 23114\u201323128 (2020).","journal-title":"Aging (Albany NY)"},{"key":"9087_CR19","doi-asserted-by":"crossref","unstructured":"Gasca, J. EDIL3 promotes epithelial\u2013mesenchymal transition and paclitaxel resistance through its interaction with integrin \u03b1V\u03b23 in cancer cells. Cell Death Discov. 6, 86 (2020).","DOI":"10.1038\/s41420-020-00322-x"},{"key":"9087_CR20","doi-asserted-by":"publisher","first-page":"101989","DOI":"10.1016\/j.mcp.2024.101989","volume":"78","author":"H Deng","year":"2024","unstructured":"Deng, H., Ning, J., Ruan, Y., Yu, W. & Cheng, F. TNFRSF11B promotes the progression of bladder cancer through PI3K\/AKT signaling pathway. Mol. Cell Probes 78, 101989 (2024).","journal-title":"Mol. Cell Probes"},{"key":"9087_CR21","doi-asserted-by":"publisher","first-page":"32902","DOI":"10.18632\/oncotarget.5361","volume":"6","author":"M Xie","year":"2015","unstructured":"Xie, M., Wu, X. J., Zhang, J. J. & He, C. S. IL-13 receptor alpha2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice. Oncotarget 6, 32902\u201332913 (2015).","journal-title":"Oncotarget"},{"key":"9087_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0054-6","volume":"7","author":"J Guo","year":"2018","unstructured":"Guo, J. et al. Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression. Oncogenesis 7, 49 (2018).","journal-title":"Oncogenesis"},{"key":"9087_CR23","doi-asserted-by":"crossref","unstructured":"Hsu, L.-Y. Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity. npj Drug Discov. 1, 2 (2024).","DOI":"10.1038\/s44386-024-00002-1"},{"key":"9087_CR24","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1158\/1078-0432.CCR-21-0206","volume":"27","author":"AM Miggelbrink","year":"2021","unstructured":"Miggelbrink, A. M. et al. CD4 T-cell exhaustion: does it exist and what are its roles in cancer? Clin. Cancer Res. 27, 5742\u20135752 (2021).","journal-title":"Clin. Cancer Res."},{"key":"9087_CR25","doi-asserted-by":"publisher","first-page":"152444","DOI":"10.1016\/j.prp.2019.152444","volume":"215","author":"YW Koh","year":"2019","unstructured":"Koh, Y. W., Han, J. H., Jeong, D. & Kim, C. J. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma. Pathol. Res Pract. 215, 152444 (2019).","journal-title":"Pathol. Res Pract."},{"key":"9087_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101742","volume":"36","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. NLRC5 potentiates anti-tumor CD8(+) T cells responses by activating interferon-beta in endometrial cancer. Transl. Oncol. 36, 101742 (2023).","journal-title":"Transl. Oncol."},{"key":"9087_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1174138","volume":"14","author":"P Farhangnia","year":"2023","unstructured":"Farhangnia, P. et al. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. Front. Immunol. 14, 1174138 (2023).","journal-title":"Front. Immunol."},{"key":"9087_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101640","volume":"5","author":"K Tooley","year":"2024","unstructured":"Tooley, K. et al. Pan-cancer mapping of single CD8(+) T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity. Cell Rep. Med. 5, 101640 (2024).","journal-title":"Cell Rep. Med."},{"key":"9087_CR29","doi-asserted-by":"crossref","unstructured":"Tsyklauri, O. et al. Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2. Elife 12, e79342 (2023).","DOI":"10.7554\/eLife.79342"},{"key":"9087_CR30","doi-asserted-by":"crossref","unstructured":"Abramiuk, M. Evaluation of CD25 and CD69 activation markers expression on peripheral blood cells subpopulations in endometriosis patients. Human Reprod. 38 (Supplement 1), i361\u2013i362 (2023).","DOI":"10.1093\/humrep\/dead093.710"},{"key":"9087_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"9087_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.350","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma. Clin. Transl. Med. 11, e350 (2021).","journal-title":"Clin. Transl. Med."},{"key":"9087_CR33","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.bbrc.2008.12.187","volume":"379","author":"A Yamada","year":"2009","unstructured":"Yamada, A. et al. IFN-gamma down-regulates Secretoglobin 3A1 gene expression. Biochem. Biophys. Res. Commun. 379, 964\u2013968 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9087_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38014","volume":"10","author":"H Guo","year":"2024","unstructured":"Guo, H. et al. Exploring tumor microenvironment in molecular subtyping and prognostic signatures in ovarian cancer and identification of SH2D1A as a key regulator of ovarian cancer carcinogenesis. Heliyon 10, e38014 (2024).","journal-title":"Heliyon"},{"key":"9087_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41586-024-07121-9","volume":"627","author":"X Guan","year":"2024","unstructured":"Guan, X. et al. Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T(reg) cells. Nature 627, 646\u2013655 (2024).","journal-title":"Nature"},{"key":"9087_CR36","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9087_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"9087_CR38","doi-asserted-by":"crossref","unstructured":"Fan, C. et al. irGSEA: the integration of single-cell rank-based gene set enrichment analysis. Brief Bioinform. 25, bbae243 (2024).","DOI":"10.1093\/bib\/bbae243"},{"key":"9087_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"9087_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Single-cell mRNA quantification and differential analysis with Census. Nat. Methods 14, 309\u2013315 (2017).","journal-title":"Nat. Methods"},{"key":"9087_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159\u2013162 (2020).","journal-title":"Nat. Methods"},{"key":"9087_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00302-5","volume":"10","author":"H Yoon","year":"2021","unstructured":"Yoon, H. et al. TGF-beta1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor. Oncogenesis 10, 13 (2021).","journal-title":"Oncogenesis"},{"key":"9087_CR43","doi-asserted-by":"publisher","first-page":"10851","DOI":"10.1007\/s00432-023-04900-1","volume":"149","author":"L Feng","year":"2023","unstructured":"Feng, L., Li, G., Li, D., Duan, G. & Liu, J. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer. J. Cancer Res. Clin. Oncol. 149, 10851\u201310865 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"9087_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28356","volume":"10","author":"C Chen","year":"2024","unstructured":"Chen, C. et al. FAT1 upregulation is correlated with an immunosuppressive tumor microenvironment and predicts unfavorable outcome of immune checkpoint therapy in non-small cell lung cancer. Heliyon 10, e28356 (2024).","journal-title":"Heliyon"},{"key":"9087_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547\u2013562 (2018).","journal-title":"Cancer Cell"},{"key":"9087_CR46","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/1878-0261.13146","volume":"16","author":"JL Gulley","year":"2022","unstructured":"Gulley, J. L. et al. Dual inhibition of TGF-beta and PD-L1: a novel approach to cancer treatment. Mol. Oncol. 16, 2117\u20132134 (2022).","journal-title":"Mol. Oncol."},{"key":"9087_CR47","doi-asserted-by":"publisher","first-page":"342391","DOI":"10.1155\/2009\/342391","volume":"2009","author":"R Samarakoon","year":"2009","unstructured":"Samarakoon, R., Higgins, C. E., Higgins, S. P. & Higgins, P. J. TGF-beta1-induced expression of the poor prognosis SERPINE1\/PAI-1 gene requires EGFR signaling: a new target for anti-EGFR therapy. J. Oncol. 2009, 342391 (2009).","journal-title":"J. Oncol."},{"key":"9087_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","volume":"40","author":"V Kleshchevnikov","year":"2022","unstructured":"Kleshchevnikov, V. et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat. Biotechnol. 40, 661\u2013671 (2022).","journal-title":"Nat. Biotechnol."},{"key":"9087_CR49","doi-asserted-by":"publisher","first-page":"115229","DOI":"10.1016\/j.celrep.2024.115229","volume":"44","author":"M Sibai","year":"2025","unstructured":"Sibai, M. et al. The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity. Cell Rep. 44, 115229 (2025).","journal-title":"Cell Rep."},{"key":"9087_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50904-x","volume":"15","author":"J Kueckelhaus","year":"2024","unstructured":"Kueckelhaus, J. et al. Inferring histology-associated gene expression gradients in spatial transcriptomic studies. Nat. Commun. 15, 7280 (2024).","journal-title":"Nat. Commun."},{"key":"9087_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101489","volume":"5","author":"Y Deng","year":"2024","unstructured":"Deng, Y. et al. Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages. Cell Rep. Med. 5, 101489 (2024).","journal-title":"Cell Rep. Med."},{"key":"9087_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40398-4","volume":"14","author":"A Castiglioni","year":"2023","unstructured":"Castiglioni, A. et al. Combined PD-L1\/TGFbeta blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors. Nat. Commun. 14, 4703 (2023).","journal-title":"Nat. Commun."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09087-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09087-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09087-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:02:47Z","timestamp":1764594167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09087-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9087"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09087-4","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.J.L. has received consulting fees from AstraZeneca, Roche, Merck, Yuhan, Bayer, and Amgen. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1730"}}